Today we are experiencing a major increase in heroin addiction. The huge increase in heroin addiction is directly related to Big Pharma and their whores; doctors. What is the connection? Opiate-derived pain killers and psychotropic anti-depressants. Doctors write prescriptions everyday for these FDA approved opiates.

WHY, you may ask, are doctors prescribing so many? The answer is money. Although denied by the AMA, the doctors are given kickbacks from the drug manufacturers. The physicians are given a set amount of money for each prescription of a said medication.

These pain killers are opium-based. Opium is a highly addictive derivative of the sap from the poppy plant. Pain killers are prescribed in such a great amount, then, the doctor stops prescribing them to you, leaving you with a physical addiction. The withdraw symptoms are exactly as if you were coming off of a heroin addiction. It causes severe sickness that can become deadly. People are dying at a rate of 44 overdoses each day. That doesn’t sound like a lot, but do the math. The cost to the hospitals is astronomical. Most that are brought in are financially broke. The addiction takes more and more money as time goes by. The costs of these FDA-approved pills, is ever increasing; they usually sell on the streets for $1 per milligram. This doesn’t take a mathematician to figure out that the user is eventually spending a couple hundred dollars per day, quickly.

There is a powerful connection between prescription painkillers and heroin, and as much as no one wants to talk about it or admit it, it’s really simple. People get addicted to prescription painkillers and heroin becomes the next step for one big reason…It’s a lot cheaper and eventually becomes easier to get. So what is happening is our suburbs are being invaded with addiction, and a new, unsuspected category of substance dependent people is emerging. The idea that since it’s not completely illegal, and it’s something that you can easily have prescribed by most doctors for legitimate reasons or poorly concocted lies about being in pain, has made a lot of people believe, somehow, that it wasn’t alarmingly dangerous to abuse these drugs. They couldn’t be more wrong.

The drug industry at one time was called the patent medicine industry. This is still the more revealing name. Drug companies devote themselves to inventing non-natural molecules for use in medicine. Why non-natural? Because molecules previously occurring in nature cannot, as a rule, be patented. It is essential to develop a patentable medicine; only a medicine protected by a government patent can hope to recoup the enormous cost of taking a new drug through the government’s approval process.

Getting a new drug through the US Food and Drug Administration (FDA) is not just expensive ($1 billion on average). It also requires having the right people on your side. Drug companies know that they must hire former FDA employees to assist with the process. They also hire leading experts as consultants, some of the same experts who may be called on by the FDA to serve on its screening panels. Direct payments must also be made to support the FDA’s budget.

All these financial ties encourage a “wink and a nod” relationship between researchers working for drug companies and regulators, who are often the same people, thanks to the revolving door.

The Economist magazine wrote:                                

“Pharmaceutical companies bury clinical trials which show bad results for a drug and publish only those that show a benefit. The trials are often run on small numbers of unrepresentative patients, and the statistical analyses are massaged to give as rosy a picture as possible. Entire clinical trials are run not as trials at all, but as under-the-counter advertising campaigns designed to persuade doctors to prescribe a company’s drug.”

The bad behavior extends far beyond the industry itself. Drug regulators, who do get access to some of the hidden results, often guard them jealously, even from academic researchers, seeming to serve the interests of the firms whose products they are supposed to police. The French journal Prescrire applied to Europe’s drug regulator for information on the diet drug rimonabant. The regulator sent back 68 pages in which virtually every sentence was blacked out. . . .

Medical journals frequently fail to perform basic checks on the papers they print, so all sorts of sharp practice goes uncorrected. Many published studies are not written by the academics whose names they bear, but by commercial ghostwriters paid by drug firms. Doctors are bombarded with advertising encouraging them to prescribe certain drugs. . . .

Although the costs of drug approval keep growing, along with the related corruption, the financial payoff for those ultimately winning approval can be astronomical, because approval also brings with it a government-protected monopoly. Only FDA-approved drugs can be prescribed within government programs such as Medicare. Doctors may prescribe unapproved substances outside of Medicare, Medicaid, or the Veteran’s Administration, but by doing so risk losing their license to practice. Some approved drugs may be priced as high as $500,000 per year per patient.

The FDA will also discourage, and often ban, substances that might compete with approved drugs. When anti-depression drugs (based on extending the life of a hormone, serotonin, inside the body) were approved, the Agency promptly banned a natural substance, L-Tryptophan, that increased serotonin, even though the natural substance was much cheaper and had long been available. Many years later, after the anti-depression drugs were well established, Tryptophan was finally allowed back, but under restrictions that made it more expensive.

In general, the FDA maintains a resolutely hostile stance toward supplements. And they are petrified by the thought of cannabis and all the ailments that can be treated with a plant. It will not allow any treatment claims to be made for them, no matter how much science there is to support it, unless they are brought through the FDA approval process and thus become drugs. The Agency understands that this is a classic “Catch-22.” Who can afford to spend up to a billion dollars to win FDA approval of a non-patented substance? The answer is obvious: no one. So the real FDA intent is simply to eliminate any competition for patented drugs, since these drugs pay the Agency’s bills.

This is why heroin in on the rise.